Search

everythinglearnresearchcommunity

for

Search:↓

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Minocycline may cause hair loss by increasing DHT levels, but finasteride can help counteract this effect.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

No significant link between CAG repeat numbers and female pattern hair loss in Han Chinese population.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Liver disease is linked to hair loss, especially in women and those with unhealthy lifestyles.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

Common noncancerous skin diseases have various treatments, including topical applications, light therapy, surgery, and medications, with psychological support being important.

Androgens can both increase and decrease hair growth in different parts of the body.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Longer CAG repeats in gene linked to more severe hair loss in females.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Androgens may block hair growth signals, targeting this could treat hair loss.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Finasteride helps treat hair loss by blocking enzyme activity.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Hair loss led to the diagnosis of Cushing's disease in a patient, showing that hair loss can be a sign of hormonal disorders.